Parkinsonism & Related Disorders
Volume 16, Issue 4 , Pages 237-242, May 2010

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review

  • L. Correia Guedes

      Affiliations

    • Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon School of Medicine, Lisbon, Portugal
    • Corresponding Author InformationCorresponding author. Tel.: +351 966280324; fax: +351 217976644.
  • ,
  • J.J. Ferreira

      Affiliations

    • Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon School of Medicine, Lisbon, Portugal
  • ,
  • M.M. Rosa

      Affiliations

    • Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon School of Medicine, Lisbon, Portugal
  • ,
  • M. Coelho

      Affiliations

    • Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon School of Medicine, Lisbon, Portugal
  • ,
  • V. Bonifati

      Affiliations

    • Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • C. Sampaio

      Affiliations

    • Neurological Clinical Research Unit, Instituto de Medicina Molecular, Lisbon School of Medicine, Lisbon, Portugal

Received 7 July 2009; received in revised form 6 November 2009; accepted 8 November 2009.

Abstract 

Background

The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease. Knowledge of its worldwide frequency distribution is essential for clinical and molecular research as well as genetic counseling.

Objectives

To conduct a systematic review of the reported frequency of G2019S in different populations and to assess critically the quality of the clinical studies.

Methods

We conducted a systematic review of all published papers on G2019S frequency in homogeneous ethnic groups or sub-groups of patients. Selected papers were analyzed for methodological quality.

Results

68 studies from 32 countries were included in the analysis. A heterogeneous distribution was observed with high frequencies in North African Arab countries, the Middle East, southern Europe, North American Ashkenazi Jewish populations and in South American countries with known European ethnic influence. Frequencies ranged from the no cases to 35.7% in sporadic and 42% in familial North-African Arab patients. Only one paper from one sub-Saharan country was found. Methodological pitfalls were identified.

Conclusions

Estimated frequencies were found to be variable, which may reflect ethnic differences and methodological discrepancies. We make recommendations on the methods of selection of participants and on the definition of familial Parkinson's disease to improve the quality of frequency studies on LRRK2 mutations.

Keywords: Frequency, G2019S, LRRK2, Parkinson's disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The review of this paper was entirely handled by the Co-Editor-in-Chief, Zbigniew Wszolek.

PII: S1353-8020(09)00276-4

doi:10.1016/j.parkreldis.2009.11.004

Parkinsonism & Related Disorders
Volume 16, Issue 4 , Pages 237-242, May 2010